GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $684,000 | 0.0% | 15,715 | +1.5% | 0.01% | +25.0% |
| Q1 2022 | $684,000 | -3.9% | 15,486 | -2.9% | 0.01% | -11.1% |
| Q4 2021 | $712,000 | +8.5% | 15,954 | -5.9% | 0.01% | 0.0% |
| Q3 2021 | $656,000 | +0.6% | 16,950 | +4.9% | 0.01% | 0.0% |
| Q2 2021 | $652,000 | +3.5% | 16,165 | -7.0% | 0.01% | 0.0% |
| Q1 2021 | $630,000 | -7.9% | 17,382 | -5.0% | 0.01% | -18.2% |
| Q4 2020 | $684,000 | -12.9% | 18,293 | -11.1% | 0.01% | -26.7% |
| Q3 2020 | $785,000 | -8.7% | 20,586 | -1.2% | 0.02% | -11.8% |
| Q2 2020 | $860,000 | +9.8% | 20,846 | +2.3% | 0.02% | 0.0% |
| Q1 2020 | $783,000 | -12.2% | 20,387 | +8.5% | 0.02% | 0.0% |
| Q4 2019 | $892,000 | +9.4% | 18,790 | -0.6% | 0.02% | +6.2% |
| Q3 2019 | $815,000 | +7.9% | 18,902 | +0.1% | 0.02% | 0.0% |
| Q2 2019 | $755,000 | +3.9% | 18,890 | +8.5% | 0.02% | 0.0% |
| Q1 2019 | $727,000 | +10.2% | 17,410 | +0.7% | 0.02% | 0.0% |
| Q4 2018 | $660,000 | -2.7% | 17,297 | +2.4% | 0.02% | +6.7% |
| Q3 2018 | $678,000 | +0.1% | 16,897 | +0.6% | 0.02% | -11.8% |
| Q2 2018 | $677,000 | +4.6% | 16,798 | +1.3% | 0.02% | 0.0% |
| Q1 2018 | $647,000 | +11.6% | 16,585 | +1.3% | 0.02% | +21.4% |
| Q4 2017 | $580,000 | -15.9% | 16,367 | -3.8% | 0.01% | -22.2% |
| Q3 2017 | $690,000 | -5.6% | 17,010 | +0.2% | 0.02% | -10.0% |
| Q2 2017 | $731,000 | +0.3% | 16,970 | -1.9% | 0.02% | -4.8% |
| Q1 2017 | $729,000 | +147.1% | 17,306 | +125.7% | 0.02% | +133.3% |
| Q4 2016 | $295,000 | -23.0% | 7,669 | -13.8% | 0.01% | -25.0% |
| Q3 2016 | $383,000 | -7.0% | 8,897 | -6.6% | 0.01% | -14.3% |
| Q2 2016 | $412,000 | -0.5% | 9,527 | -6.8% | 0.01% | 0.0% |
| Q1 2016 | $414,000 | -14.5% | 10,222 | -14.9% | 0.01% | -17.6% |
| Q4 2015 | $484,000 | +6.4% | 12,007 | +1.4% | 0.02% | 0.0% |
| Q3 2015 | $455,000 | +35.8% | 11,839 | +46.8% | 0.02% | +54.5% |
| Q2 2015 | $335,000 | +22.7% | 8,062 | +35.9% | 0.01% | +22.2% |
| Q1 2015 | $273,000 | +14.7% | 5,931 | +6.5% | 0.01% | +12.5% |
| Q4 2014 | $238,000 | +6.7% | 5,570 | +14.6% | 0.01% | +14.3% |
| Q3 2014 | $223,000 | -54.6% | 4,859 | -47.2% | 0.01% | -61.1% |
| Q2 2014 | $491,000 | +8.6% | 9,199 | +8.6% | 0.02% | +5.9% |
| Q1 2014 | $452,000 | +46.3% | 8,471 | +46.2% | 0.02% | +54.5% |
| Q4 2013 | $309,000 | +8.0% | 5,795 | +1.6% | 0.01% | 0.0% |
| Q3 2013 | $286,000 | +22.2% | 5,701 | +21.3% | 0.01% | +10.0% |
| Q2 2013 | $234,000 | – | 4,701 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |